ANRO
Alto Neuroscience, Inc.
NYSE · Healthcare · Biotechnology · US
$22.61
−0.40%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 95.59x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.05x
- Price / sales
- —
- Price / cash flow
- -12.99x
Enterprise value
- Enterprise value
- $650.6M
- EV / sales
- —
- EV / EBITDA
- -8.00x
- EV / EBIT
- 14.63x
- Market cap
- $887.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026